About Huan-Chin Hsu
Huan-Chin Hsu chairs TCM Life Science and its parent, TCM Biotech International. TCM Biotech says he has decades of pharmaceutical sales experience.
He is also an advisor to Taiwan's Executive Yuan and president of the National Innovation and Entrepreneurship Association.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Huan-Chin Hsu in the role, so the role may have started earlier or lasted longer.
TCM Life Science Inc. Current
Chairman
2026 – Present · Newark, DE
TCM Life Science is developing the oral, non-antibiotic U101 candidate to prevent recurrent urinary tract infections.
TI
TCM Biotech International Current
Chairman
EC
Executive Yuan, Republic of China Current
Advisor
NC
National Innovation and Entrepreneurship Association, R.O.C. Current
President
Key Colleagues at Startups
The people Huan-Chin Hsu works with at each company, as listed on that company's latest Form D.
TCM Life Science Inc. · Form D, Oct 26, 2026
Ya-Chun Wang
Director and Chief Executive Officer
Huan-Chin Hsu in the News
- [TCM Biotech FY2026 Q3 Earnings Call] U101 U.S. Phase III Trial Launch Imminent; Subsidiary TCM Life Science Valued at $550 Million, Raising $55 Million in Series A
- 【TCM Biotech FY2026 H1 Earnings Call】U101 Phase III Enrollment Surpasses 60%, Interim Analysis Looms in Q3; FDA Greenlights 505(b)(2) Pathway Saving Tens of Millions of Dollars; U.S. Subsidiary Established to Accelerate Global Licensing